Skip to main content

Workers spray insecticide to combat the Zika virus in Rio de Janeiro, Brazil, on Jan. 26, 2016.

Leo Correa/AP

Researchers infected pregnant monkeys with the Zika virus to learn how it harms developing fetuses – and in a highly unusual twist, the public can get a real-time peek at the findings.

Among the first surprising results: While most people harbour Zika in their bloodstream for only a week or so after infection, the virus lingered in one pregnant monkey's blood for 70 days and in another for 30 days.

A bit of good news: Tests with non-pregnant monkeys suggest one infection with Zika protects against a second bout later on.

Story continues below advertisement

Rhesus macaque monkeys make a good model for studying how Zika infects people, researchers at the University of Wisconsin-Madison concluded Tuesday in Nature Communications. But what's novel is that the team is posting its raw data online right away – even ultrasound images of developing monkeys that they acknowledged at the time "can elicit stronger emotions than looking at relatively sterile charts" – so that normally competing research labs can work together to speed discoveries.

That collaboration will help "use as few animals as possible to answer important research questions," lead researcher David O'Connor, a pathology professor at UW-Madison, told reporters. "We hope this will encourage others to make their data available in real time to accelerate the response time to Zika virus and other outbreaks in the future."

A handful of other labs have joined in the movement to share their own data from Zika-infected monkeys in real time.

"This is how research should be, especially for emerging diseases that are causing so many problems," said Koen Van Rompay of the California National Primate Research Center at the University of California, Davis. He and O'Connor have begun consulting to avoid duplicating experiments. "We are in a race against the virus, a race against time. We should not be competing against each other," Van Rompay added.

The Zika virus, which is spread mainly by a tropical mosquito, is causing an epidemic in Latin America and the Caribbean. It causes only a mild illness, at worst, in most people but can cause severe brain-related birth defects if woman are infected during pregnancy. No one knows how big the risk is, or how to tell which pregnancies will be affected.

O'Connor's team gave monkeys a skin jab with a strain of Zika virus to mimic a mosquito bite. Tuesday's paper compiles results from eight animals. Much like people, the six non-pregnant monkeys cleared Zika out of the bloodstream fairly quickly, in about 10 days.

And when researchers attempted to infect them with the same strain 10 weeks later, they didn't get sick – evidence that it should be possible to design a protective vaccine, O'Connor said.

Story continues below advertisement

"We don't know how long this immunity lasts," cautioned study co-author Dawn Dudley, but that's a key question for women in countries hard-hit by the virus.

Another big issue: Why the two pregnant monkeys, infected during the first trimester, had infections linger drastically longer – something reported so far in only one human case, which ended in abortion.

When those monkey babies are delivered by C-section and euthanized next month, their tissues and placenta will be carefully examined for Zika. One theory is that if a fetus is infected, it will pump virus back into mom's blood, O'Connor said.

"We might hypothesize that the pregnancy with the longest duration of extended viremia is more likely to have abnormalities detected at birth, but right now that's simply a hypothesis," he cautioned.

O'Connor's team also infected two more monkeys in the third trimester of pregnancy; tests on those babies' brains and other tissues are under way.

Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter